SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Return
62.95%
This Quarter Return
+0.93%
1 Year Return
-62.95%
3 Year Return
-60.35%
5 Year Return
-56.94%
10 Year Return
–
AUM
$235M
AUM Growth
-$71.7M
(-23%)
Cap. Flow
-$80M
Cap. Flow
% of AUM
-34.08%
Top 10 Holdings %
Top 10 Hldgs %
35.12%
Holding
862
New
116
Increased
55
Reduced
76
Closed
146
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$24.4M |
| 2 |
Moderna
MRNA
|
$9.14M |
| 3 |
Amgen
AMGN
|
$7.8M |
| 4 |
Pinduoduo
PDD
|
$5.6M |
| 5 |
Bank of America
BAC
|
$4.84M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$31M |
| 2 |
Biogen
BIIB
|
$8.77M |
| 3 |
Aon
AON
|
$6.33M |
| 4 |
Sunrun
RUN
|
$4.78M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$4.73M |
Sector Composition
| 1 | Healthcare | 27.19% |
| 2 | Communication Services | 15.29% |
| 3 | Consumer Discretionary | 14.51% |
| 4 | Technology | 12.96% |
| 5 | Financials | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Viatris
VTRS
$12.1B
| $96K | ﹤0.01% |
6,700
-128,300
| -95% | -$1.84M |
|
|
JMIA
227
Jumia Technologies
JMIA
$1.13B
| $94K | ﹤0.01% |
3,110
-13,360
| -81% | -$404K |
|
|
DISCK
228
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $87K | ﹤0.01% |
+3,000
| New | +$87K |
|
229
Boston Scientific
BSX
$160B
| $86K | ﹤0.01% |
+2,000
| New | +$86K |
|
230
Esperion Therapeutics
ESPR
$512M
| $85K | ﹤0.01% |
+4,000
| New | +$85K |
|
231
Tencent Music
TME
$37.8B
| $85K | ﹤0.01% |
5,500
-24,500
| -82% | -$379K |
|
232
Sea Limited
SE
$114B
| $82K | ﹤0.01% |
300
-13,700
| -98% | -$3.74M |
|
233
Chewy
CHWY
$17.4B
| $80K | ﹤0.01% |
1,000
-4,500
| -82% | -$360K |
|
|
HUYA
234
Huya Inc
HUYA
$765M
| $71K | ﹤0.01% |
+4,000
| New | +$71K |
|
235
Kratos Defense & Security Solutions
KTOS
$10.7B
| $71K | ﹤0.01% |
+2,500
| New | +$71K |
|
236
Shift4
FOUR
$5.94B
| $70K | ﹤0.01% |
+750
| New | +$70K |
|
|
AGC
237
DELISTED
Altimeter Growth Corp. Class A Ordinary Shares
AGC
| $69K | ﹤0.01% |
+5,900
| New | +$69K |
|
238
Procter & Gamble
PG
$371B
| $67K | ﹤0.01% |
+500
| New | +$67K |
|
239
Kamada
KMDA
$420M
| $64K | ﹤0.01% |
+11,000
| New | +$64K |
|
240
Wynn Resorts
WYNN
$12.8B
| $61K | ﹤0.01% |
+500
| New | +$61K |
|
|
ARBGU
241
DELISTED
Aequi Acquisition Corp. Unit
ARBGU
| $60K | ﹤0.01% |
6,000
-3,801
| -39% | -$38K |
|
242
Starbucks
SBUX
$95.8B
| $56K | ﹤0.01% |
500
-19,500
| -98% | -$2.18M |
|
|
IMGN
243
DELISTED
Immunogen Inc
IMGN
| $56K | ﹤0.01% |
+8,500
| New | +$56K |
|
244
Icahn Enterprises
IEP
$4.82B
| $55K | ﹤0.01% |
1,000
-1,000
| -50% | -$55K |
|
245
Li Auto
LI
$24B
| $52K | ﹤0.01% |
+1,500
| New | +$52K |
|
|
RNWK
246
DELISTED
RealNetworks Inc
RNWK
| $51K | ﹤0.01% |
22,000
-1,360
| -6% | -$3.15K |
|
247
Monster Beverage
MNST
$61.3B
| $46K | ﹤0.01% |
+1,000
| New | +$46K |
|
248
Pool Corp
POOL
$12.3B
| $46K | ﹤0.01% |
100
-900
| -90% | -$414K |
|
249
Plains GP Holdings
PAGP
$3.63B
| $42K | ﹤0.01% |
+3,500
| New | +$42K |
|
250
Assembly Biosciences
ASMB
$180M
| $39K | ﹤0.01% |
+833
| New | +$39K |
|